Abstract
Purpose. In this work, the alacepril thiolesterase, which catalyzes the hydrolyzing reaction of the thiolester linkage in alacepril and the conversion from alacepril to deacetylalacepril, was purified from rat liver cytosol and characterized.
Methods. A purification procedure for the thiolesterase consisted of ammonium sulfate fractionation and chromatographies with phenyl Sepharose CL-4B, Q Sepharose FF, ceramic hydroxylapatite, and phenyl Sepharose HP. The thiolesterase activity was assayed for alacepril as a substrate and the reaction product, deacetylalacepril, was measured using high-performance liquid chromatography.
Results. The purified thiolesterase is heterodimeric with a molecular mass of 29 and 36 kDa subunits as estimated by sodium dodecyl sulfate -polyacrylamide gel electrophoresis. N-terminal amino acid sequence of these subunits reveals that the thiolesterase is identical to sialic acid 9-O-acetylesterase. The thiolesterase hydrolyzes not only the thiolester bond in alacepril, spironolactone, and acetyl coenzyme A but also the carboxylester bond in α-naphtyl acetate. The alacepril thiolestrase activity is competitively inhibited by α-naphtyl acetate.
Conclusion. The thiolesterase, i.e., sialic acid 9-O-acetylesterase, seems to be involved in the metabolism of certain drugs such as alacepril and spironolactone. However, drugs having ester-type and amide-type linkages, for example dilazep, aniracetam, and benazepril, are not substrates for the thiolestrase.
Similar content being viewed by others
REFERENCES
M. A. Ondetti, B. Rubin, and D. W. Cushman. Design of specific inhibitors of angiotensin-converting enzyme: New class of orally active antihypertensive agents. Science 196:441-444 (1997).
K. Takeyama, H. Minato, F. Fukuya, S. Kawahara, K. Hosoki, and T. Kadokawa. Antihypertesive activity of alacepril, an orally active angiotensin converting enzyme inhibitor, in renal hypertensive rats and dogs. Arzneim-Forsch/Drug Res. 35:1502-1507 (1985).
K. Matsumoto, H. Miyazaki, T. Fujii, K. Yoshida, H. Amejima, and M. Hashimoto. Disposition and metabolism of the novel antihypertensive agent alacepril in rats. Arzneim-Forsch/Drug Res. 36:40-46 (1985).
P. Corvol, A. Michaud, F. Soubrier, and T. A. Williams. Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. J. Hypertens. Suppl. 13:3-10 (1995).
F. M. Williams. Clinical significance of esterases in man. Clin. Pharmacokinet. 10:392-403 (1985).
M. S. Bogdanffy, R. Sarangapani, J. S. Kimbell, S. R. Frame, and D. R. Plowchalk. Analysis of vinyl acetate metabolism in rat and human nasal tissues by an in vitro gas uptake technique. Toxicol. Sci. 46:235-246 (1998).
S. Guichard, C. Terret, I. Hennebelle, I. Lochon, P. Chevreau, E. Fretigny, J. Selves, E. Chatelut, R. Bugat, and P. Canal. CPT-11 converting carboxylesterase and topoisomerase activities in tumor and normal colon and liver tissues. Br. J. Cancer 80:364-370 (1999).
F. Ahmed, V. Vyas, A. Cornfield, S. Goodin, T. S. Ravilumar, E. H. Rubin, and E. Gupta. In vitro activation of irinotecan to SN-38 by human liver and intestine. Anticancer Res. 19:2067-2071 (1999).
B. Yan, D. Yang, M. Brady, and A. Parkinson. Rat kidney carboxylesterase. Cloning, sequencing, cellular localization, and relationship to rat liver hydrolase. J. Biol. Chem. 269:29688-29696 (1994).
T. Yamada, N. Kawaguchi, M. Hosokawa, and T. Satoh. Location of an isoform of carboxylesterase in rat brain differs from that in human brain. Brain Res. 674:175-177 (1995).
H. Schwer, T. Langmann, R. Daig, A. Becker, C. Aslanidis, and G. Schmitz. Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver. Biochem. Biophys. Res. Commun. 233:117-120 (1997).
B. Yan, L. Matoney, and D. Yang. Human carboxylesterase in term placenta: enzymatic characterization, molecular cloning and evidence for the existence of multiple forms. Placenta 20:599-607 (1999).
Y. H. Park and S. S. Lee. Identification and characterization of capsocin-hydrolyzing enzymes purified from rat liver microsomes. Biochem. Mol. Biol. Int. 34:351-360 (1994).
T. Satoh, M. Hosokawa, R. Atsumi, W. Suzuki, H. Hakusui, and E. Nagai. Metabolic activation of CPT-11,7-ethyl-10-[4-(1-piperidino)-1-piperidine] carbonyloxycamptothecin, a novel anticancer agent, by carboxylesterase. Biol. Pharm. Bull. 17:662-664 (1994).
R. Mentlein and E. Heymann. Hydrolysis of ester-and amide-type drugs by the purified isoenzymes of nonspecific carboxylesterase from rat liver. Biochem. Pharmacol. 33:1243-1248 (1984).
H. Yan and J. J. Harding. Inactivation and loss of antigenicity of esterase by sugar and a steroid. Biochim. Biophys. Acta 1454:183-190 (1999).
M. Hosokawa and T. Satoh. Differences in the induction of carboxylesterase isozymes in rat liver microsomes by perfluorinated fatty acids. Xenobiotica 23:1125-1133 (1993).
M. Lotti and A. Moretto. Promotion of organophosphate induced delayed polyneuropathy by esterase inhibitors. Chem. Biol. Interact. 199-120:519-524 (1999).
R. Zech, R. M. Severin, J. M. Chemnitius, and K. Nebendahl. Paraoxonase polymorphism in rabbits. Chem. Biol. Interact. 119-120:283-288 (1999).
M. Hosokawa, K. Suzuki, D. Takahashi, M. Mori, T. Satoh, and K. Chiba. Purification, molecular cloning, and functional expression of dog liver microsomal acyl-CoA hydrolase: a member of the carboxylesterase multigene family. Arch. Biochem. Biophys. 389:245-253 (2001).
L. Luan, T. Sugiyama, S. Takai, Y. Usami, T. Adachi, Y. Katagiri, and K. Hirano. Purification and characterization of pranlukast hydrolase from rat liver microsomes: the hydrolase is identical to carboxylesterase pI 6.2. Biol. Pharm. Bull. 20:71-75 (1997).
K. Terashima, S. Takai, Y. Usami, T. Adachi, T. Sugiyama, Y. Katagiri, and K. Hirano. Purification and partial characterization of an indomethacin hydrolyzing enzyme from pig liver. Pharm. Res. 13:1327-1335 (1996).
M. Sugiura, Y. Iizumi, T. Adashi, Y. Ito, K. Hirano, and S. Sawaki. Studies on human urinary and renal esterases that migrate to the Γ-globulin #x00AEion upon cellulose acetate electrophoresis. Chem. Pharm. Bull. 29:2920-2927 (1981).
R. L. Prass, F. Isohashi, and M. F. Utter. Purification and characterization of an extramitochondrial acetyl coenzyme A hydrolase form rat liver. J. Biol. Chem. 255:5215-5223 (1980).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
U. K. Laemmli. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:689-695 (1970).
I. Towbin, T. Staehelin, and J. Gordon. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354 (1979).
M. Hosokawa, T. Maki, and T. Satoh. Multiplicity and #x00AEulation of hepatic microsomal carboxylesterase in rats. Mol. Pharmacol. 31:579-584 (1987).
R. Mentlein, A. Ronai, M. Robbi, E. Heymann, and O. von Deimling. Genetic identification of rat liver carboxylesterases isolated in different laboratories. Biochim. Biophys. Acta 913:27-38 (1987).
E. W. Morgan, B. Yan, D. Greenway, D. R. Petersen, and A. Perkinson. Purification and characterization of two rat liver microsomal carboxylesterases (hydrolase A and B). Arch. Biochem. Biophys. 315:495-512 (1994).
B. Yan, D. Yang, and Perkinson. Cloning and expression of hydrolase C, a member of the rat carboxylesterase family. Arch. Biochem. Biophys. 317:222-234 (1995).
C. Butor, H. H. Higa, and A. Varki. Structural, immunological, and biosynthetic studies of a sialic acid-specific O-acetylesterase from rat liver. J. Biol. Chem. 268:10207-10213 (1993).
M. J. Guimaraes, J. F. Bazan, J. Castagnola, S. Diaz, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, A. Varki, and A. Zlotnik. Molecular cloning and characterization of lysosomal sialic acid O-acetylesterase. J. Biol. Chem. 271:13697-13705 (1996).
H. H. Higa, A. Manzi, and A. Varki. O-acetylation and de-O-acetylation of sialic acids. Purification, characterization of a glycosylated rat liver esterase specific for 9-O-acetylated sialic acids. J. Biol. Chem. 264:19435-19442 (1989).
R. Schauer. Sialic acids: metabolism of O-acetyl groups. Methods Enzymol. 138:611-626 (1987).
H. Tatematsu, S. Diaz, A. Stoddart, Y. Zhang, and A. Varki. Lysosomal and cytosolic sialic acid 9-O-acetylesterase activities can be encoded by one gene via differential usage of a single peptide-encoding exon at the N ter#x2014. J. Biol. Chem. 274:25623-25631 (1999).
H. H. Higa, C. Butor, S. Diaz, and A. Varki. O-acetylation and de-O-acetylation of sialic acids. O-acetylation of sialic acids in the rat liver golgi apparatus involves an acetyl intermediate and essential histidine and lysine residues-a transmembrane reaction? J. Biol. Chem. 264:19427-19434 (1989).
B. K. Hayes and A. Varki. O-acetylation and de-O-acetylation of sialic acids. Sialic acid esterases of diverse evolutionary origins have serine active sites and essential arginine residues. J. Biol. Chem. 264:19443-19448 (1989).
R. Schauer, G. Reuter, and S. Stoll. Sialate O-acetylesterases: key enzymes in sialic acid catabolism. Biochimie 70:1511-1519 (1988).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Usui, S., Kubota, M., Iguchi, K. et al. Sialic Acid 9-O-Acetylesterase Catalyzes the Hydrolyzing Reaction from Alacepril to Deacetylalacepril. Pharm Res 20, 1309–1316 (2003). https://doi.org/10.1023/A:1025073720126
Issue Date:
DOI: https://doi.org/10.1023/A:1025073720126